FIELD: medicine, oncology, pharmacy. SUBSTANCE: invention relates to novel composition used for treatment or prophylaxis of prostate cancer comprising N-[1-methyl-1-(4- -methoxyphenyl)ethyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carbox-amide as active component and to method of treatment or prophylaxis of prostate cancer using the composition. EFFECT: enhanced activity of composition. 6 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT AGAINST ALOPECIA | 1998 |
|
RU2193887C2 |
| COMPOSITION OF INHIBITOR OF 5α-REDUCTASE FOR ORAL ADMINISTRATION, METHOD OF ITS PREPARING AND USE | 1997 |
|
RU2154467C2 |
| 3-CYANOANDROSTA-3,5-DIENE-17BETA-CARBOXYLIC ACID AS INTERMEDIATE PRODUCT, AND METHOD OF PREPARING COMPOUNDS | 1993 |
|
RU2114861C1 |
| PREPARATION FOR TREATING AND PREVENTING CACHEXIA | 1998 |
|
RU2190399C2 |
| AZASTEROIDAL COMPOUNDS | 1991 |
|
RU2070204C1 |
| STEROID COMPOUNDS, METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2097387C1 |
| FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS | 2003 |
|
RU2320670C2 |
| METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE | 1992 |
|
RU2125879C1 |
| FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2125061C1 |
| 17$$$-SUBSTITUTED 3-CARBOXYSTEROIDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2104283C1 |
